Dr. Fahd Al-Saghir, MD

Dr. Al-Saghir practices at North Oakland Dialysis in Rochester Hills, Michigan.

Dr. Al-Saghir's NPI, 1073584223, was assigned on January 27, 2006. Dr. Al-Saghir holds Michigan license 4301057207.

Dr. Al-Saghir's primary practice is North Oakland Dialysis, at 1886 W Auburn Rd, Rochester Hills, MI 48309 in Oakland County. The practice phone is (248) 333-2230.

Dr. Al-Saghir's primary practice is North Oakland Dialysis in Rochester Hills, Michigan. Dr. Al-Saghir is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Michigan Kidney Consultants. Dmand AI also links Dr. Al-Saghir to 4 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Saghir practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Al-Saghir's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Al-Saghir is board certified in internal medicine by the American Board of Internal Medicine. Dr. Al-Saghir is licensed in Michigan.

CMS data shows 4,117 Medicare services from Dr. Al-Saghir across 28 procedure codes in 2024, for 425 Medicare patients. Medicare paid $278,658 for them.

CMS counts 425 Medicare patients who saw Dr. Al-Saghir in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 5.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Saghir's median patient age at 71, with 42% women.

In 2024, Dr. Al-Saghir wrote 1,134 Medicare Part D claims for 162 patients. 85% of them were for generic drugs. CMS names the drug for 929 of them, across 28 drugs with 11 or more claims each, at $138,219 in total drug cost. In 2023, CMS named 828 claims across 24 drugs.

Dr. Al-Saghir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al-Saghir as offering telehealth.

CMS Open Payments shows 535 general payments to Dr. Al-Saghir from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Keryx Biopharmaceuticals, Inc. paid the most, $21,728.